title: [First NOAK with specific antidote].
authors.affiliation: .
authors.forename: Dirk
authors.initials: D
authors.lastname: Einecke
mesh_terms: D000284:Administration, Oral; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D000069604:Dabigatran / Q000008:administration & dosage* / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D020521:Stroke / Q000517:prevention & control*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; C000594745:idarucizumab; D000069604:Dabigatran